A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Clinical trial NCT01253564 · COMPLETED

Trial details

NCT number: NCT01253564
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2010-11-22
Primary completion: 2012-03-14
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.